Hypergastrinemia and a duodenal ulcer caused by gastric duplication

Hideaki Tanaka1, Kouji Masumoto2, Takato Sasaki2

  • 1Department of Pediatric Surgery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, Ibaraki Prefecture, 305-8575, Japan. tanaka-h@md.tsukuba.ac.jp.

Surgical Case Reports
|July 29, 2016
PubMed

Insights

Gastric duplication, a rare cause of hypergastrinemia, was identified in a child with a duodenal ulcer. Surgical resection resolved the hypergastrinemia and ulcer, suggesting duplication as a key differential diagnosis.

Area of Science:

  • Pediatric Gastroenterology
  • Surgical Pathology

Background:

  • Hypergastrinemia and peptic ulcers are rarely associated with enteric duplication.
  • This case highlights a unique presentation in a pediatric patient.

Purpose of the Study:

  • To report a rare case of hypergastrinemia and duodenal ulcer caused by gastric duplication in a child.
  • To emphasize the importance of considering gastric duplication in the differential diagnosis of unexplained hypergastrinemia in pediatric patients.

Main Methods:

  • Case report of a 4-year-old girl with hypergastrinemia and duodenal ulcer.
  • Diagnostic workup included imaging and histological examination after surgical resection of a cystic lesion.
  • Treatment involved proton pump inhibitors initially, followed by surgical intervention.

Main Results:

  • A 4-year-old girl presented with hypergastrinemia and a duodenal ulcer.
  • Surgical resection of a cystic lesion, confirmed as gastric duplication, led to the resolution of hypergastrinemia and ulcer.
  • Histology revealed antral mucosa within the duplication, suggesting abnormal gastrin release.

Conclusions:

  • Gastric duplication should be considered in the differential diagnosis of persistent hypergastrinemia in children.
  • This finding expands the understanding of rare causes of pediatric hypergastrinemia and peptic ulcer disease.
Abstract

Related Concept Videos

Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.7K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
985
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.4K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
750
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.5K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.4K